The Cigna Group’s Stock Price Plummets to $282.98, Marking a Steep 6.70% Decline

The Cigna Group (CI)

282.98 USD -20.33 (-6.70%) Volume: 5.47M

The Cigna Group’s stock price stands at 282.98 USD, experiencing a significant drop of -6.70% this trading session with a trading volume of 5.47M, yet showcasing a positive year-to-date (YTD) performance with a percentage increase of +2.48%.

Latest developments on The Cigna Group

Cigna Group (NYSE:CI) has experienced a rollercoaster of events leading up to its stock price movements today. Despite reporting impressive Q4 sales and profits exceeding $3 billion in 2024, the company faced challenges as medical costs impacted quarterly profits. Cigna took steps to limit out-of-pocket drug costs for US patients and announced plans to lower prescription drug costs. However, the stock plummeted after missing earnings estimates and disappointing 2025 outlook, causing investors to question the company’s performance. Despite efforts to boost buyback programs and increase dividends, Cigna’s stock fell short of expectations, reflecting the impact of elevated medical costs on the company’s financial health.

The Cigna Group on Smartkarma

According to Baptista Research on Smartkarma, analyst coverage of Cigna Group highlights the company’s third-quarter 2024 earnings, which showed shareholders’ net income of $739 million or $2.63 per share. Despite this positive result, there was a significant non-cash after-tax net realized investment loss of $1 billion related to VillageMD, impacting the figures. This loss has been excluded from adjusted operating income and earnings per share, but it is important to note in evaluating the company’s performance.

Baptista Research‘s bullish sentiment on Cigna Group is driven by the company’s specialty market position and biosimilars strategy, as mentioned in their research report titled “Cigna Corporation: Specialty Market Position & Biosimilars Strategy Driving Our Bullishness! – Major Drivers.” This analysis sheds light on key factors influencing the company’s outlook and potential for growth in the market. Investors and stakeholders can refer to this report on Smartkarma for a detailed understanding of Cigna Group‘s current position and future prospects.

A look at The Cigna Group Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Cigna Group is positioned well for the long-term. With strong scores in Value and Dividend, investors can expect solid returns and consistent payouts. While the Growth, Resilience, and Momentum scores are slightly lower, indicating some areas for improvement, overall the outlook for Cigna Group remains positive.

The Cigna Group, operating as an insurance company, offers a range of insurance products and services to individuals, families, and businesses globally. With a focus on providing life, accident, disability, supplemental, medicare, and dental insurance, Cigna Group plays a crucial role in the insurance market. Investors can take comfort in the company’s strong Value and Dividend scores, signaling stability and potential for growth in the long run.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma